Coronary stenting and use of abciximab

Lancet. 1998 Oct 17;352(9136):1312. doi: 10.1016/S0140-6736(05)70524-9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Abciximab
  • Angioplasty, Balloon*
  • Antibodies, Monoclonal / adverse effects*
  • Anticoagulants / adverse effects*
  • Humans
  • Immunoglobulin Fab Fragments / adverse effects*
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / adverse effects*
  • Thrombocytopenia / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Abciximab